Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content



2015-03-30@16:46:50 ET
Potential Biogen Idec (BIIB) Trade Has 8.03% Downside Protection (FBM)

2015-03-30@10:11:20 ET
Biogen Idec Gives Way to the Analysts: Down 9.7% Since Last Week's Downgrade (F70)

2015-03-30@08:55:00 ET
Today's Review on Biotech Equities -- Biocept, Biogen Idec, Kite Pharma, Organovo Holdings, and Bluebird Bio (PRN)

2015-03-30@05:18:00 ET
Research and Markets: Global Crohn's Disease (CD) Market 2015-2019: Key Players are AbbVie, Astra Zeneca, Biogen Idec, Johnson & Johnson, Takeda Pharmaceutical & UCB (BIZ)

2015-03-30@03:39:36 ET
Global Crohn's Disease (CD) Market 2015-2019: Key Players are AbbVie, Astra Zeneca, Biogen Idec, Johnson & Johnson, Takeda Pharmaceutical & UCB (MTO)

2015-03-30@02:00:00 ET
Biogen Announces EMA Validation of Marketing Authorization Application for SB2, a Biosimilar Candidate for Infliximab (BIZ)

2015-03-27@12:52:58 ET
Biogen Idec has the Highest Free Cash Flow Per Share in the Biotechnology Industry (BIIB, AMGN, GILD) (F70)

2015-03-27@11:30:26 ET
Biogen Idec (BIIB) Trading Near $414.94 Support Level (FBM)

2015-03-27@08:30:31 ET
Albumin (Excipient) Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2020 (MTO)

2015-03-27@07:00:01 ET
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA(TM) (Daclizumab High-Yield Process) for Treatment of MS (BIZ)

2015-03-27@04:33:54 ET
Form 4: Update Filing for Biogen Inc (BIIB) (VKR)

2015-03-26@10:40:24 ET
Biogen Idec (BIIB) Showing Bullish Technicals With Resistance At $456.62 (FBM)

2015-03-25@18:12:34 ET
Biogen reports encouraging interim data from Phase Ib Alzheimer's disease study (DTM)

2015-03-25@16:51:21 ET
Look for Shares of Biogen Idec to Potentially Rebound after Yesterday's 4.66% Sell Off (PSM)

2015-03-25@16:50:51 ET
Biogen Idec Set to Possibly Rebound After Yesterday's Selloff of 4.66% (PSM)

2015-03-25@12:25:21 ET
Biogen Idec Has Returned 32.9% Since SmarTrend Recommendation (BIIB) (PSM)

2015-03-25@12:22:02 ET
Stock Investors Sell Off Shares of Biogen Idec, Down 2.3% (F77)